Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Vitamin D is crucial for skin health and managing skin diseases.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Notch signaling disruptions can cause various skin diseases.

Zebrafish are useful for studying and developing treatments for human skin diseases.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.